Curated News
By: NewsRamp Editorial Staff
March 20, 2026
Catalyst Crew Seeks FINRA Approval to Rebrand as LataMed AI Corp.
TLDR
- Catalyst Crew Technologies Corp. is rebranding to LataMed AI Corp. to better position itself in the AI healthcare market, potentially offering investors early entry into a focused Latin American strategy.
- The company has submitted a request to FINRA to change its name and trading symbol, a process requiring board and shareholder approval but no alteration to its capital structure.
- This rebrand to LataMed AI Corp. reflects a strategic shift toward using AI to improve healthcare access and efficiency in emerging markets, starting with Latin America.
- A company is changing its name from Catalyst Crew Technologies to LataMed AI Corp. to signal its new focus on artificial intelligence in healthcare.
Impact - Why it Matters
This corporate rebranding signals a pivotal shift for Catalyst Crew Technologies as it fully commits to the AI healthcare technology sector, specifically targeting Latin America. For investors, it represents a strategic realignment that could enhance the company's market positioning and appeal in a high-growth industry without diluting existing share value. For the healthcare landscape in emerging markets, the company's focus on AI-driven solutions like telehealth and data analytics promises to address critical gaps in access and efficiency, potentially improving care delivery for millions. However, as a development-stage company with no revenue from this new direction, it carries significant execution risk, making this announcement a key indicator for monitoring its transition from concept to operational reality.
Summary
Catalyst Crew Technologies Corp. (OTC: CCTC), an artificial intelligence-driven healthcare technology company, has taken a significant step in its strategic evolution by submitting a corporate action request to the Financial Industry Regulatory Authority (FINRA). The company seeks approval to change its name to LataMed AI Corp. and adopt a corresponding new trading symbol. This move is designed to better reflect the company's current strategic direction, which has transitioned toward developing AI-enabled healthcare technology solutions, including healthcare analytics and technology-enabled healthcare services infrastructure, with an initial strategic focus on Latin America.
The proposed change was approved by the Company's Board of Directors and its majority shareholder in accordance with Nevada law. Importantly, the company emphasizes that this corporate action does not involve any reverse stock split, forward stock split, recapitalization, or other modification to its capital structure. The issued and outstanding share count will remain unchanged, and the name change and corresponding trading symbol change will not affect shareholders' ownership interests, requiring no action from existing shareholders. Dr. Kevin Rodan Levy, Chief Executive Officer, stated that the change is intended to better align the company's public identity with its healthcare technology strategy and long-term market focus. However, the company cautions that no assurance can be given that FINRA will approve the proposed name change, the requested new trading symbol, or the timing of any such approval.
Upon FINRA approval, the company intends to file a Certificate of Amendment with the Nevada Secretary of State to effect the corporate name change. The change would become effective upon completion of required corporate filings and publication by FINRA on the Daily List. For more information, stakeholders are directed to visit the company's website or review its filings with the U.S. Securities and Exchange Commission. The original release can be viewed on www.newmediawire.com. The company describes itself as focused on developing scalable digital health solutions for emerging markets, with initiatives across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination in regions like Latin America.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Catalyst Crew Seeks FINRA Approval to Rebrand as LataMed AI Corp.
